- Table of Contents
In 2018, more than 266,000 women will be diagnosed with breast cancer in the United States. According to the American Cancer Society, over 40,000 women will die from breast cancer this year. It is the second leading cause of cancer death in American women. Breast cancer is the most common cancer in women in the US and worldwide, regardless of race or ethnicity.
Every October, organizations around the world unite to raise awareness for breast cancer. Many government and non-profit organizations, such as NIEHS, CDC, and Susan G. Komen, have devoted resources and funding to support research studies and encourage screening for early detection. For example, the American Cancer Society has provided $61 million of funding for breast cancer as of August 2018.
In support of breast cancer research, Boster Bio offers a range of products related to breast cancer. Click below to find out more about breast cancer, the international campaign, research funding, and Boster tools for your research.
Download troubleshootingnhandbooks for IHC, Western blot and ELISA for FREE.Troubleshooting guides
Get better results with Boster!
Boster takes great measures to ensure product quality and to provide our customers with comprehensive data upfront. Our antibodies are validated using WB, IHC, and flow cytometry against a panel of over 250 tissues and un-transfected cell lines to ensure high affinity and crystal-clear IHC stains. In addition, we also validate our antibodies in a quantitative fashion by testing them on known quantities of recombinant proteins so that you know what to expect (e.g. if there is 1ng, 2.5ng or 5ng of the target protein in the sample). Every product is covered by the Boster Quality Guarantee, click below to learn more.
Have questions? We're here to help.